# Continuing advanced therapies before elective Crohn's surgery may reduce serious complications

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-advanced-therapies-elective-crohn-surgery.html) · 2026-11-20 · Medicine
Page: https://themorning.science/story/continuing-advanced-therapies-before-elective-crohn-s-surgery-may-reduce-serious-736aed261ad04493
Kind: research · Impact: medium

## In brief

- Patients with Crohn's disease who continue advanced therapies such as biologics and small-molecule drugs before elective colorectal surgery may have a lower risk of certain postoperative complications.
- The two complications named in the source are anastomotic leak and organ space surgical site infection.
- The source reports an association, not a proven causal effect of continuing therapy.

## Why it matters

For clinicians and researchers treating Crohn's disease, the findings suggest that perioperative drug management may influence surgical outcomes, which could inform future guidance on whether to continue or pause advanced therapies before elective surgery.

## Timeline

- 2026-11-20: Medical Xpress reports findings on continuing advanced therapies before elective Crohn's surgery

## Coverage

- [Continuing advanced therapies before elective Crohn's surgery may reduce serious complications](https://medicalxpress.com/news/2026-11-advanced-therapies-elective-crohn-surgery.html) — Medical Xpress - latest medical and health news stories, 2026-11-20

Tags: crohn's disease, colorectal surgery, biologics, surgical complications, inflammatory bowel disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
